NLTX Annual ROA
-49.64%
-12.47%-33.55%
31 December 2022
Summary:
As of February 5, 2025, NLTX annual return on assets is -49.64%, with the most recent change of -12.47% (-33.55%) on December 31, 2022. During the last 3 years, it has fallen by -2.41% (-5.10%).NLTX ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLTX Quarterly ROA
-34.43%
+4.93%+12.53%
30 September 2023
Summary:
As of February 5, 2025, NLTX quarterly return on assets is -34.43%, with the most recent change of +4.93% (+12.53%) on September 30, 2023. Over the past year, it has increased by +6.74% (+16.37%).NLTX Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLTX ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.5% | +16.4% |
| 3 y3 years | -5.1% | -99.8% |
| 5 y5 years | -9.2% | +20.2% |
NLTX ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | +214.0% | +99.8% |
Neoleukin Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | -34.43%(-12.5%) |
| June 2023 | - | -39.36%(-16.6%) |
| Mar 2023 | - | -47.20%(+8.4%) |
| Dec 2022 | -49.64%(+33.5%) | -43.55%(+5.8%) |
| Sept 2022 | - | -41.17%(+4.4%) |
| June 2022 | - | -39.44%(+9.0%) |
| Mar 2022 | - | -36.18%(+8.3%) |
| Dec 2021 | -37.17%(+135.1%) | -33.42%(+11.1%) |
| Sept 2021 | - | -30.08%(+37.0%) |
| June 2021 | - | -21.95%(+7.8%) |
| Mar 2021 | - | -20.36%(+11.7%) |
| Dec 2020 | -15.81%(-66.5%) | -18.22%(+5.7%) |
| Sept 2020 | - | -17.23%(-74.1%) |
| June 2020 | - | -66.48%(-2.8%) |
| Mar 2020 | - | -68.42%(-9.8%) |
| Dec 2019 | -47.23%(+16.1%) | -75.89%(-15.0%) |
| Sept 2019 | - | -89.32%(+218.1%) |
| June 2019 | - | -28.08%(+26.4%) |
| Mar 2019 | - | -22.21%(-35.8%) |
| Dec 2018 | -40.69% | -34.57%(-19.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | -43.16%(+17.1%) |
| June 2018 | - | -36.86%(-24.8%) |
| Mar 2018 | - | -49.03%(+24.2%) |
| Dec 2017 | -45.48%(+89.7%) | -39.47%(+20.7%) |
| Sept 2017 | - | -32.69%(+17.3%) |
| June 2017 | - | -27.88%(+1.6%) |
| Mar 2017 | - | -27.45%(-2.2%) |
| Dec 2016 | -23.97%(+24.3%) | -28.07%(+8.6%) |
| Sept 2016 | - | -25.84%(+0.5%) |
| June 2016 | - | -25.72%(+7.2%) |
| Mar 2016 | - | -23.99%(-18.7%) |
| Dec 2015 | -19.29%(-66.5%) | -29.50%(-31.8%) |
| Sept 2015 | - | -43.28%(-34.3%) |
| June 2015 | - | -65.89%(+11.9%) |
| Mar 2015 | - | -58.86%(+23.2%) |
| Dec 2014 | -57.51%(-39.8%) | -47.77%(-1.3%) |
| Sept 2014 | - | -48.39%(+3.7%) |
| June 2014 | - | -46.65%(+2.5%) |
| Mar 2014 | - | -45.51%(-52.3%) |
| Dec 2013 | -95.48%(-81.6%) | -95.47% |
| Dec 2012 | -518.27% | - |
FAQ
- What is Neoleukin Therapeutics annual return on assets?
- What is the all time high annual ROA for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics annual ROA year-on-year change?
- What is Neoleukin Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics quarterly ROA year-on-year change?
What is Neoleukin Therapeutics annual return on assets?
The current annual ROA of NLTX is -49.64%
What is the all time high annual ROA for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high annual return on assets is -15.81%
What is Neoleukin Therapeutics annual ROA year-on-year change?
Over the past year, NLTX annual return on assets has changed by -12.47% (-33.55%)
What is Neoleukin Therapeutics quarterly return on assets?
The current quarterly ROA of NLTX is -34.43%
What is the all time high quarterly ROA for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high quarterly return on assets is -17.23%
What is Neoleukin Therapeutics quarterly ROA year-on-year change?
Over the past year, NLTX quarterly return on assets has changed by +6.74% (+16.37%)